An activity of:

Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V. Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V.

Who we are: The "Deutsche Vereinigung zur Bekämpfung von Viruskrankheiten e.V." (DVV) was founded in Berlin on 31 August 1954 as an interdisciplinary instrument for doctors and scientists in practice, clinic, research institutes and health authorities. It is supported by the Federal Ministry of Health, the health ministries of the federal states, scientific societies and socially committed foundations and organisations. In addition, the DVV is supported and financially supported in fulfilling its statutory tasks by the Fördererverein zur Bekämpfung der Viruskrankheiten.


Gesellschaft für Virologie e.V. Gesellschaft für Virologie e.V.

Who we are: The "Gesellschaft für Virologie e.V." (GfV) pursues the goal of promoting virology in all fields by increasing and exchanging knowledge in the field of virology research, especially in German-speaking countries. This is to be achieved, among other things, through scientific conferences, the promotion of publications and cooperation with other scientific societies. The society promotes academic teaching and education as well as professional training. It provides advisory services to scientific institutions, research supporting organisations and political and social bodies in so far as scientific aspects of virology, academic education and professional training are concerned.



Who we are: MEDEORA GmbH supports the Clinical Virology Network in all technical terms. We also take care about the contractual arrangements with the sponsors and financial settlement.

MEDEORA GmbH (a University Hospital of Cologne spin-off) is a privately owned company for more than 12 years. Our specialization is the development of individual solutions for the needs of pharmaceutical industry and medical science.

Our products include software solutions for the management of biological samples and patient data and the implementation of scientific research projects and pharmaceutical studies.

As an ISO 9001 certified company we place great emphasis on structured and sustainable processes.

Contact: Dr. Norbert Schmeißer

Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.

Who we are: The Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) was founded in May 1967 in Frankfurt/Main and aims to form a regional association of human and veterinary physicians, natural scientists and those who support these interests and are interested in chemotherapy, its basics and its application. The Society aims to promote research and teaching in these fields by exchanging experiences, organising scientific events and joint scientific research.


Gold partners

Janssen Janssen

Who we are: Coming soon.

More information here: and

Qiagen Qiagen

Who we are: Qiagen.

Seqirus Seqirus

Who we are: Seqirus.

As one of the largest influenza vaccine providers in the world, Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. We are devoted to protecting people and communities across the globe – working each and every day with our partners on the front line of public health. To learn more visit

Wer wir sind: Seqirus.

Als einer der größten Anbieter von Grippeimpfstoffen weltweit leistet Seqirus einen wichtigen Beitrag zur weltweiten Grippeprävention und ist ein transkontinentaler Partner bei der Pandemievorsorge. Wir engagieren uns für den Schutz von Menschen und Gemeinschaften auf der ganzen Welt und arbeiten jeden Tag mit unseren Partnern an vorderster Front im Bereich der öffentlichen Gesundheit zusammen. Um mehr zu erfahren, besuchen Sie

Silver partners

AbbVie AbbVie

Who we are: AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.

Contact: Dieter Schmidt

aprimeo aprimeo

Who we are: aprimeo diagnostics GmbH & Co. KG is focused on the distribution of innovative, next-level diagnostic solutions. The partnership with BOSCH Healthcare Solutions (BHCS) enables us to provide the innovative molecular diagnostic platform Vivalytic to healthcare professionals, enabling them making the best therapy decision for their patients each and every day. A broad range of molecular diagnostic tests, a comprehensive assay pipeline as well as the convenient, easy-to-use and straight-forward workflow sets the Vivalytic platform apart from other Near-Patient solutions.

Contact: Dr. Frank Apostel and Diana Martens

Luminex Luminex

Who we are: The company develops, manufactures and markets molecular test systems for clinical diagnostics and the life science industry. The Luminex xMAP® Multi-Analyte, MultiCode® Real-Time PCR and Multiplex PCR technologies deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies.

Contact: Jörg Willuhn

R-Biopharm R-Biopharm

Who we are: R-Biopharm AG – innovative, reliable and proven solutions from a single source

We have developed innovative products in the field of clinical diagnostics as well as for food and animal feed analysis since1988. Laboratories, hospitals and food producers throughout the world appreciate our high quality and customer-oriented solutions. Starting from a business with 6 employees, the company founder and Chairman of the Board of Directors Dr Ralf M. Dreher has developed R-Biopharm AG into an international biotechnology company. Our continuing growth and responsible management repeatedly made us the winners of the „Sustainability Award“ for sustainable action. R-Biopharm AG is still managed by its founder and combines development, production and sales under a single roof.

Contact: Dr. Andreas Simons and Dr. Katharina Wystub-Lis


Who we are: TIB MOLBIOL - a ISO 13485 certified  company - provides for more than 25 years custom oligonucleotides and qPCR kits to customers worldwide.
ModularDx kits: Combine six and more assays in one multiplex qPCR for use in high-throughput screening - with an ultimative flexibility through the option to exchange assays. Kits cover respiratory and other pathogens. Available through Roche Diagnostics.

Contact: Olfert Landt

Bronze partners

Abbott Abbott

Who we are: At Abbott, we're committed to helping people live their best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.


altona Diagnostics altona Diagnostics

Who we are: Founded in Hamburg in 2007, the company aims to develop and commercialize real-time PCR-based assays and molecular diagnostic test solutions in the field of infectious diseases. altona Diagnostics offers a broad range of complete, CE-IVD marked real-time PCR kits. We focus especially on emerging pathogens and on the development of customized solutions.



Who we are: The healthcare and diagnostics company strives to make advances towards greater certainty for its customers by providing cutting-edge technology. HOLOGIC works to achieve both incremental and transformational progress to improve patients' lives. The company's core offerings are Breast & Skeletal Health, Diagnostic, GYN Surgical and Medical Aesthetic Solutions.


Siemens Healthineers Deutschland Siemens Healthineers Deutschland

Who we are: Siemens Healthcare Diagnostics, a global leader in clinical diagnostics, provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. Our innovative portfolio of performance-driven solutions and personalized customer carecombine to streamline workflow, enhance operational efficiency, and support improved patient outcomes.

Contact: Anne Beyou Zuliani

Further supporter

Roche Roche

Who we are: Roche employs around 15,900 people in Germany in the pharmaceutical and diagnostics sectors. The major operating companies are represented at the three sites in Grenzach-Wyhlen (Roche Pharma AG), Mannheim (Roche Diagnostics GmbH, Roche Diagnostics Deutschland GmbH, Roche Diabetes Care GmbH and Roche Diabetes Care Deutschland GmbH) and Penzberg (Biotechnology Competence Centre, Roche Diagnostics GmbH). The focus is on the entire value chain of the Pharmaceuticals and Diagnostics divisions: from research and development to production, logistics, marketing and sales.

Contact: Dr. Marcel Jung